|
|
| | MY-5445 Basic information |
| Product Name: | MY-5445 | | Synonyms: | MY-5445;1-(3-CHLOROPHENYLAMINO)-4-PHENYLPHTHALAZINE;1-(3-CHLOROANILINO)-4-PHENYLPHTHALAZINE;N-(3-Chlorophenyl)-4-phenyl-1-phthalazinamine;N-(3-chlorophenyl)-4-phenylphthalazin-1-amine;MY 5445;MY5445;1-(3-Chloroanilino)-4-phenylphthalazine >;aggregation,platelet,Inhibitor,anticancer,inhibit,MY5445,neuropathic,MY 5445,Phosphodiesterase (PDE),neuropathic pain,allodynia,MY-5445 | | CAS: | 78351-75-4 | | MF: | C20H14ClN3 | | MW: | 331.8 | | EINECS: | | | Product Categories: | Cyclic Nucleotide related | | Mol File: | 78351-75-4.mol |  |
| | MY-5445 Chemical Properties |
| Boiling point | 539.7±50.0 °C(Predicted) | | density | 1.310±0.06 g/cm3(Predicted) | | storage temp. | Store at RT | | solubility | DMF: 2 mg/ml; DMSO: 2 mg/ml; DMSO:PBS(pH 7.2) (1:2): 0.3 mg/ml | | pka | 4.91±0.30(Predicted) | | form | Yellow solid. | | color | White to Light yellow |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36 | | HS Code | 2933.99.8290 |
| | MY-5445 Usage And Synthesis |
| Description | MY-5445 is a selective inhibitor of the cyclic GMP (cGMP) phosphodiesterase, PDE5, with a Ki value of 1.3 μM. It inhibits calcium- and cAMP-selective PDEs with Ki values of >1,000 and 915 μM, respectively. MY-5445 has been shown to relax intact strips of rat aorta with an EC50 value of 4 μM. | | Uses | MY-5445 is a selective cGMP phosphodiesterase inhibitor. Potent PDE5 inhibitor. | | Definition | ChEBI: N-(3-chlorophenyl)-4-phenyl-1-phthalazinamine is a ring assembly and a member of pyridazines. | | Biological Activity | Specific inhibitor of cyclic GMP phosphodiesterase, selective for PDE5 (IC 50 = 0.5 μ M). |
| | MY-5445 Preparation Products And Raw materials |
|